Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Personalis (PSNL) Change in Accured Expenses: 2018-2025

Historic Change in Accured Expenses for Personalis (PSNL) over the last 7 years, with Sep 2025 value amounting to $1.8 million.

  • Personalis' Change in Accured Expenses fell 22.70% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 137.36%. This contributed to the annual value of -$2.4 million for FY2024, which is 423.58% down from last year.
  • Personalis' Change in Accured Expenses amounted to $1.8 million in Q3 2025, which was up 25.55% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, Personalis' Change in Accured Expenses registered a high of $3.4 million during Q1 2022, and its lowest value of -$7.8 million during Q1 2024.
  • For the 3-year period, Personalis' Change in Accured Expenses averaged around -$103,182, with its median value being $760,000 (2024).
  • Over the last 5 years, Personalis' Change in Accured Expenses had its largest YoY gain of 375.36% in 2024, and its largest YoY loss of 1,939.44% in 2024.
  • Personalis' Change in Accured Expenses (Quarterly) stood at $1.5 million in 2021, then crashed by 89.97% to $153,000 in 2022, then crashed by 280.39% to -$276,000 in 2023, then surged by 375.36% to $760,000 in 2024, then fell by 22.70% to $1.8 million in 2025.
  • Its Change in Accured Expenses was $1.8 million in Q3 2025, compared to $1.4 million in Q2 2025 and -$2.7 million in Q1 2025.